Kevin M Pantalone, Bruce Rogen, Patty Zirm, Huijun Xiao, James Bena, Gretchen Barnard, Elena Borukh, Seenia Peechakara, Marcio L Griebeler, James B Young, Bartolome Burguera
INTRODUCTION: This study aimed to compare weight loss and glycated hemoglobin (HbA1c )-reduction effects of two obesity-centric, weight-loss management approaches (with or without anti-obesity medication) versus usual glucose-centric care in patients with obesity and type 2 diabetes. METHODS: Single-center, randomized, open-label, 3-armed, parallel-group, pragmatic, noninferiority trial, July 2020 to August 2022. Adults enrolled in the Cleveland Clinic Employee Health Plan (body mass index [BMI] ≥ 30 kg/m2 , type 2 diabetes diagnosis, HbA1c > 7...
April 4, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders